Page last updated: 2024-09-03

deramciclane and Anxiety Disorders

deramciclane has been researched along with Anxiety Disorders in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahokas, A; Jokinen, R; Kanerva, H; Koponen, H; Lehtonen, L; Lepola, U; Mäki-Ikola, O; Naukkarinen, H; Partanen, A; Penttinen, J; Pohjalainen, T; Raassina, R; Rouru, J	1
Kõks, S; Vasar, E	1

Reviews

1 review(s) available for deramciclane and Anxiety Disorders

Article	Year
Deramciclane (Egis). Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:2 Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Camphanes; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drugs, Investigational; Humans; Lethal Dose 50; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Treatment Outcome	2002

Article

Year

Deramciclane (Egis).

Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:2

Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Camphanes; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drugs, Investigational; Humans; Lethal Dose 50; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Treatment Outcome

2002

Trials

1 trial(s) available for deramciclane and Anxiety Disorders

Article	Year
Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2005, Volume: 15, Issue:6 Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Camphanes; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence	2005

Article

Year

Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2005, Volume: 15, Issue:6

Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Camphanes; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence

2005